Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $600 US for a two-pack of the device from less than $100 in 2007.
from CBC | Health News http://ift.tt/2oxMFUe
Aucun commentaire:
Enregistrer un commentaire